Thomas Malley - Jun 6, 2023 Form 4 Insider Report for Kiniksa Pharmaceuticals, Ltd. (KNSA)

Role
Director
Signature
/s/ Madelyn Zeylikman, Attorney-in-Fact
Stock symbol
KNSA
Transactions as of
Jun 6, 2023
Transactions value $
$0
Form type
4
Date filed
6/8/2023, 04:23 PM
Previous filing
Jun 2, 2023
Next filing
Jun 20, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction KNSA Share Option Award $0 +26.2K $0.00 26.2K Jun 6, 2023 Class A Common Shares 26.2K $15.19 Direct F1
transaction KNSA Restricted Share Units Award $0 +4.37K $0.00 4.37K Jun 6, 2023 Class A Common Shares 4.37K Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests and becomes exercisable in twelve substantially equal monthly installments following the date of the grant. The date of the grant is June 6, 2023.
F2 Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Common Share of the Issuer.
F3 The RSUs vest in their entirety on the first anniversary of the date of the grant, June 6, 2023.